Ionis Pharmaceuticals (IONS) PT Lowered to $55 at BofA Securities
Tweet
Share
E-mailGet Alerts IONS Hot Sheet
Price: $44.44 -4.94%
Rating Summary:
17 Buy, 11 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 19 | Down: 9 | New: 26
Rating Summary:
17 Buy, 11 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 19 | Down: 9 | New: 26
Join SI Premium – FREE
BofA Securities analyst Jason Gerberry lowered the price target on Ionis Pharmaceuticals (NASDAQ: IONS) to $55.00 (from $56.00) while maintaining a Buy rating.
You May Also Be Interested In
- Ionis Pharmaceuticals (IONS) PT Lowered to $80 at Guggenheim
- Manila Electric Co (MER:PM) (MAEOY) PT Lowered to PHP500 at CLSA
- China Cinda Asset Management (1359:HK) PT Lowered to HK$0.95 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
